Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas
- 11 March 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 254 (1-2) , 119-125
- https://doi.org/10.1016/0014-2999(94)90378-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non‐adrenoceptor idazoxan binding sitesBritish Journal of Pharmacology, 1993
- A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline ReceptorsJournal of Cardiovascular Pharmacology, 1992
- The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cellsEuropean Journal of Pharmacology, 1991
- Block of ATP‐regulated potassium channels by phentolamine and other α‐adrenoceptor antagonistsBritish Journal of Pharmacology, 1991
- Mechanisms involved in stimulation of insulin secretion by the hypoglycaemic alpha-adrenergic antagonist, DG-5128Biochemical and Biophysical Research Communications, 1991
- Stimulation of insulin secretion by efaroxan may involve interaction with potassium channelsEuropean Journal of Pharmacology, 1990
- Effects of α‐adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouseActa Physiologica Scandinavica, 1985
- Studies on RX 781094: a selective, potent and specific antagonist of α2‐adrenoceptorsBritish Journal of Pharmacology, 1983
- Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed ratsDiabetologia, 1975
- ROLE OF ADRENERGIC RECEPTORS IN GLUCOSE-INDUCED INSULIN SECRETION IN MANThe Lancet, 1969